Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Biolab Sanus Farmaceutica Ltda. - Product Pipeline Review - 2014

Published: Dec-2014 | Format: PDF | Global Markets Direct | Number of pages: 24 | Code: MRS - 18622


Global Markets Directs, Biolab Sanus Farmaceutica Ltda. Product Pipeline Review 2014, provides an overview of the Biolab Sanus Farmaceutica Ltda.s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Biolab Sanus Farmaceutica Ltda.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

The report provides brief overview of Biolab Sanus Farmaceutica Ltda. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Biolab Sanus Farmaceutica Ltda.s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the Biolab Sanus Farmaceutica Ltda.s pipeline products

Reasons to buy

Evaluate Biolab Sanus Farmaceutica Ltda.s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Biolab Sanus Farmaceutica Ltda. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Biolab Sanus Farmaceutica Ltda.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Biolab Sanus Farmaceutica Ltda. and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Biolab Sanus Farmaceutica Ltda.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Biolab Sanus Farmaceutica Ltda. and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents
List of Tables
List of Figures
Biolab Sanus Farmaceutica Ltda. Snapshot
Biolab Sanus Farmaceutica Ltda. Overview
Key Information
Key Facts
Biolab Sanus Farmaceutica Ltda.- Research and Development Overview
Key Therapeutic Areas
Biolab Sanus Farmaceutica Ltda.- Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products- Monotherapy
Biolab Sanus Farmaceutica Ltda.- Pipeline Products Glance
Biolab Sanus Farmaceutica Ltda.- Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Biolab Sanus Farmaceutica Ltda.- Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
Biolab Sanus Farmaceutica Ltda.- Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Biolab Sanus Farmaceutica Ltda.- Drug Profiles
BL-123
Product Description
Mechanism of Action
R&D Progress
BL-125
Product Description
Mechanism of Action
R&D Progress
PB-5109
Product Description
Mechanism of Action
R&D Progress
BL-122
Product Description
Mechanism of Action
R&D Progress
BL-214
Product Description
Mechanism of Action
R&D Progress
BL-249
Product Description
Mechanism of Action
R&D Progress
Biolab Sanus Farmaceutica Ltda.- Pipeline Analysis
Biolab Sanus Farmaceutica Ltda.- Pipeline Products by Target
Biolab Sanus Farmaceutica Ltda.- Pipeline Products by Route of Administration
Biolab Sanus Farmaceutica Ltda.- Pipeline Products by Molecule Type
Biolab Sanus Farmaceutica Ltda.- Pipeline Products by Mechanism of Action
Biolab Sanus Farmaceutica Ltda.- Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables

Biolab Sanus Farmaceutica Ltda., Key Information
Biolab Sanus Farmaceutica Ltda., Key Facts
Biolab Sanus Farmaceutica Ltda.- Pipeline by Indication, 2014
Biolab Sanus Farmaceutica Ltda.- Pipeline by Stage of Development, 2014
Biolab Sanus Farmaceutica Ltda.- Monotherapy Products in Pipeline, 2014
Biolab Sanus Farmaceutica Ltda.- Phase III, 2014
Biolab Sanus Farmaceutica Ltda.- Phase I, 2014
Biolab Sanus Farmaceutica Ltda.- Preclinical, 2014
Biolab Sanus Farmaceutica Ltda. -Pipeline by Target, 2014
Biolab Sanus Farmaceutica Ltda.- Pipeline by Route of Administration, 2014
Biolab Sanus Farmaceutica Ltda.- Pipeline by Molecule Type, 2014
Biolab Sanus Farmaceutica Ltda.- Pipeline Products by Mechanism of Action, 2014
Biolab Sanus Farmaceutica Ltda., Other Locations

List of Figures

Biolab Sanus Farmaceutica Ltda. - Pipeline by Top 10 Indication, 2014
Biolab Sanus Farmaceutica Ltda. - Pipeline by Stage of Development, 2014
Biolab Sanus Farmaceutica Ltda. - Monotherapy Products in Pipeline, 2014
Biolab Sanus Farmaceutica Ltda. - Pipeline by Top 10 Molecule Type, 2014

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing